Stephen L. Silvestro
Net Worth

Last updated:

What is Stephen L. Silvestro net worth?

The estimated net worth of Mr. Stephen L. Silvestro is at least $5,952,153 as of 3 Oct 2024. He owns shares worth $50,240 as insider, has earned $3,959,673 from insider trading and has received compensation worth at least $1,942,240 in OptimizeRx Corporation.

What is the salary of Stephen L. Silvestro?

Mr. Stephen L. Silvestro salary is $485,560 per year as Chief Commercial Officer in OptimizeRx Corporation.

How old is Stephen L. Silvestro?

Mr. Stephen L. Silvestro is 47 years old, born in 1978.

What stocks does Stephen L. Silvestro currently own?

As insider, Mr. Stephen L. Silvestro owns shares in one company:

Company Title Shares Price per share Total value
OptimizeRx Corporation (OPRX) Chief Commercial Officer 3,200 $15.7 $50,240

What does OptimizeRx Corporation do?

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

OPRX logo
OPRX
OptimizeRx Corporation
$15.7

Stephen L. Silvestro insider trading

OptimizeRx Corporation

Mr. Stephen L. Silvestro has made 8 insider trades between 2021-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 90,000 units of OPRX stock on 2 May 2024. As of 3 Oct 2024 he still owns at least 3,200 units of OPRX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 6,649 N/A N/A
Option
Common Stock 6,649 N/A N/A
Option
Common Stock 90,000 N/A N/A
Option
Restricted Stock Units 90,000 N/A N/A
Option
Restricted Stock Units 1,927 N/A N/A
Option
Common Stock 1,927 N/A N/A
Option
Restricted Stock Units 6,649 N/A N/A
Option
Common Stock 6,649 N/A N/A
Option
Restricted Stock Units 1,927 N/A N/A
Option
Common Stock 1,927 N/A N/A
Purchase
Common Stock 3,200 $15.66 $50,112
Sale
Common Stock pursuant to 10B5-1 plan 13,241 $54.87 $726,534
Option
Common Stock 13,241 $7.51 $99,440
Option
Stock Option 13,241 $7.51 $99,440
Option
Stock Option 13,241 $7.51 $99,440
Option
Common Stock 13,241 $7.51 $99,440
Sale
Common Stock pursuant to 10B5-1 plan 13,241 $73.98 $979,569
Sale
Common Stock pursuant to 10B5-1 plan 13,241 $85.38 $1,130,517
Option
Common Stock 13,241 $7.51 $99,440
Option
Stock Option 13,241 $7.51 $99,440
Option
Stock Option 13,242 $7.51 $99,447
Option
Common Stock 13,242 $7.51 $99,447
Sale
Common Stock pursuant to 10B5-1 plan 13,242 $69.79 $924,159
Option
Common Stock 13,242 $7.51 $99,447
Option
Stock Option 13,242 $7.51 $99,447
Sale
Common Stock pursuant to 10B5-1 plan 13,242 $7.51 $99,447
Sale
Common Stock pursuant to 10B5-1 plan 13,242 N/A N/A
Option
Common Stock 13,242 N/A N/A
Option
Stock Option 13,242 N/A N/A
Option
Stock Option 13,242 $7.51 $99,447
Sale
Common Stock pursuant to 10B5-1 plan 13,242 $7.51 $99,447
Option
Common Stock 13,242 $7.51 $99,447
Sale
Common Stock 13,242 N/A N/A
Option
Stock Option 13,242 N/A N/A
Option
Common Stock 13,242 N/A N/A

OptimizeRx key executives

OptimizeRx Corporation executives and other stock owners filed with the SEC: